Mark Warner Discusses Implications for Canada from President Trump’s Drug Import Proposals
Mark Warner was interviewed on Newstalk 1010 about President Trump’s proposals to facilitate certain pharmaceutical imports from Canada to the United States. (August 1, 2019) Mr. Warner was Legal Director of the Ontario Ministry of Economic Development & Trade and advised Ontario in the negotiation of the Canada – EU Trade Agreement (CETA) including on drug pricing and patent appeals and on other trade and investment negotiation and dispute settlement matters including NAFTA . Mr. Warner, a Canadian and U.S. lawyer, has advised pharmaceutical companies on pricing, distribution and other competition and trade matters. Mr. Warner has also governments on trade policy and trade negotiations and previously worked on trade and competition issues as counsel in the OECD Trade Directorate.
Share this article
Share this insight with your network or send via email.
Topic Keywords:

Mark Warner
Principal · MAAW LAW
Mark Warner is a business-oriented, results-driven, senior international business and regulatory expert with private practice, government, and academic experience in Canada, the United States, Europe and major emerging markets.